GLP-1 Weight Loss Drugs Face New FDA Warning Over Rare Vision Loss Risk: What Patients Need to Know
The US FDA has announced a new safety warning for GLP-1 medicines, including Ozempic, Wegovy and Mounjaro, highlighting a possible association with NAION, a rare eye condition that can cause permanent vision loss. Patients should understand the warning and seek immediate medical attention if they experience sudden changes in vision. Popular GLP-1 weight loss medications, … Read more